PRICE T ROWE ASSOCIATES INC /MD/ - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 177 filers reported holding TG THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$446
-94.0%
53,339
-82.1%
0.00%
-100.0%
Q2 2023$7,404
+560.5%
298,039
+300.1%
0.00%
Q1 2023$1,121
+2.3%
74,494
-19.6%
0.00%
Q4 2022$1,096
-99.8%
92,666
-11.4%
0.00%
Q3 2022$620,000
+45.5%
104,583
+4.3%
0.00%
Q2 2022$426,000
-92.3%
100,257
-82.7%
0.00%
-100.0%
Q1 2022$5,525,000
-50.0%
580,975
-0.0%
0.00%0.0%
Q4 2021$11,039,000
-76.7%
580,992
-59.2%
0.00%
-75.0%
Q3 2021$47,429,000
-35.1%
1,425,148
-24.3%
0.00%
-42.9%
Q2 2021$73,067,000
-6.3%
1,883,651
+16.5%
0.01%
-12.5%
Q1 2021$77,956,000
+7.0%
1,617,341
+15.5%
0.01%
+14.3%
Q4 2020$72,872,000
+5238.6%
1,400,845
+2646.3%
0.01%
Q3 2020$1,365,000
+520.5%
51,009
+29.8%
0.00%
Q3 2018$220,000
-57.0%
39,297
+0.9%
0.00%
Q2 2018$512,000
-9.2%
38,948
-2.0%
0.00%
Q1 2018$564,000
+30.6%
39,736
-24.7%
0.00%
Q4 2017$432,000
+146.9%
52,736
+257.9%
0.00%
Q3 2017$175,000
+18.2%
14,7360.0%0.00%
Q2 2017$148,000
-13.5%
14,736
+0.2%
0.00%
Q1 2017$171,000
+151.5%
14,7000.0%0.00%
Q4 2016$68,000
-40.4%
14,7000.0%0.00%
Q3 2016$114,00014,7000.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,890,000$15,800,4005.14%
Ghost Tree Capital, LLC 1,000,000$8,360,0002.75%
Soleus Capital Management, L.P. 2,884,382$24,113,4342.22%
M28 Capital Management LP 216,600$1,810,7762.08%
Paradigm Biocapital Advisors LP 3,619,015$30,254,9652.05%
683 Capital Management, LLC 1,350,000$11,286,0000.88%
Parkwood LLC 165,414$6,0810.66%
Spotlight Asset Group, Inc. 79,000$660,4400.60%
Pier Capital, LLC 392,709$3,283,0470.53%
Quantum Private Wealth, LLC 91,081$761,4380.36%
View complete list of TG THERAPEUTICS INC shareholders